No abstract available
MeSH terms
-
Biosimilar Pharmaceuticals* / economics
-
Biosimilar Pharmaceuticals* / pharmacology
-
Biosimilar Pharmaceuticals* / therapeutic use
-
Drug Costs
-
Drug Utilization / trends
-
European Union
-
Humans
-
Marketing of Health Services
-
National Health Programs
-
Patient Acceptance of Health Care
-
Prescription Fees
-
Spain
-
Therapeutic Equivalency
Substances
-
Biosimilar Pharmaceuticals